Animal models of asthma - Pro: Allergic avoidance of animal (model[s]) is not an option

American Journal of Respiratory and Critical Care Medicine

Volumn 174, Issue 11, 2006, Pages 1171-1173

  Shapiro, Steven D ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; INTERLEUKIN 5 ANTIBODY;

ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; DATA ANALYSIS; DISEASE MODEL; EXPERIMENTAL MODEL; GENE MUTATION; HUMAN; IMMUNE RESPONSE; LUNG DEVELOPMENT; LUNG STRUCTURE; NONHUMAN; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; SHORT SURVEY;

ANIMALS; ASTHMA; DISEASE MODELS, ANIMAL; FIBROSIS; LUNG; MICE;

EID: 33845540077     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.2609001     Document Type: Short Survey

References (16)

1. Shapiro S, Demeo D. Genomic physiology in animals. In: Silverman EK, Shapiro SD, Lomas D, Weiss SA, editors. Respiratory genetics. Oxford: Hodder-Arnold; 2005. pp. 177-190.
2. Tormanen KR, Uller L, Persson CG, Erjefalt JS. Allergen exposure of mouse airways evokes remodeling of both bronchi and large pulmonary vessels. Am J Respir Crit Care Med 2005;171:19-25.
3. Valerius K. Size-dependent morphology of the condutive bronchial tree in four species of myomorph rodents. J Morphol 1996;230:291-297.
4. Hautamaki RD, Kobayashi DK, Senior RM, Shapiro SD. Macrophage elastase is required for cigarette smoke-induced emphysema in mice. Science 1997;277:2002-2004.
5. Johnson L, Mercer K, Greenbaum D, Bronson RT, Crowley D, Tuveson DA, Jacks T. Somatic activation of the K-ras oncogene causes early onset lung cancer in mice. Nature 2001;410:1111-1116.
6. Ji H, Li D, Chen L, Shimamura T, Kobayashi S, McNamara K, Mahmood U, Sun Y, Al-Hashem R, et al. The impact of human EGFR kinase domain mutations on lung tumorigenesis and in vivo sensitivity to EGFR-targeted therapies. Cancer Cell 2006;9:485-495.
7. Chua F, Gauldie J, Laurent GJ. Pulmonary fibrosis: searching for model answers. Am J Respir Cell Mol Biol 2005;33:9-13.
8. Dahl ME, Dabbagh K, Liggitt D, Kim S, Lewis DB. Viral-induced T helper type 1 responses enhance allergic disease by effects on lung dendritic cells. Nat Immunol 2004;5:337-343.
9. Riese RJ, Finn PW, Shapiro SD. Influenza and asthma: adding to the respiratory burden. Nat Immunol 2004;5:243-244.
10. Foster P, Hogan S, Ramsay A, Matthaei K, Young I. Interleukin-5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model. J Exp Med 1996;183:195-201.
11. Cho Y, Miller M, Baek K, et al. Inhibition of airway remodeling in IL-5-deficient mice. J Clin Invest 2004;113:551-560.
12. Leckie M, Brinke At, Khan J, et al. Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response. Lancet 2000;356:2144-2148.
13. Kips J, O'Connor B, Langley S, et al. Effect of SCH55700, a humanized anti-human interleukin-5 antibody, in severe persistent asthma: a pilot study. Am J Respir Crit Care Med 2003;167:1655-1659.
14. Humbles AA, Lloyd CM, McMillan SJ, et al.A critical role for eosinophils in allergic airways remodeling. Science 2004;305:1776-1779.
15. Bates J, Irvin C, Brusasco V, et al. The use and misuse of Penh in animal models of lung disease. Am J Respir Cell Mol Biol 2004;31:373-374.
16. Paigen K. A miracle enough: the power of mice. Nat Med 1995;1:215-220.